Brazil - Low-Cost Vaccine Production for Developing Countries

The goal is to produce as much as 30 million doses per year by 2017, at a price of about fifty cents (Euro) per dose. These vaccines are intended only for export to countries in the developing world: Africa, Asia and Latin America.
Currently, the only low-cost vaccines are produced in India. This is why the Bill and Melinda Gates Foundation will finance this project with a million dollars, entrusting the production of vaccines to a Brazilian factory built ad hoc, called Bio-Manguinohs.

Vaccines at low cost of production will be used to fight rubella and measles, diseases that are dangerous in countries in the developing world.